Pink Ribbon Run 2023

Choose from the 4-mile run or the 2-mile walk and join us on Saturday, May 13th at the Lutheran Hospital campus.

As it has since 2014, the Pink Ribbon Run will benefit the Vera Bradley Foundation for Breast Cancer, which raises funds for breast cancer research to find a cure and to improve the lives of the many affected by this disease. Vera Bradley’s co-founders began raising funds after the loss of a dear friend to the disease in 1993. The Foundation has contributed $36 million to the Vera Bradley Foundation Center for Breast Cancer Research at Indiana University School of Medicine in Indianapolis, Indiana. The Center is focused on developing and dramatically improving therapies for some of the most difficult-to-treat types of breast cancer, including triple negative breast cancer. Funds are raised through special events, partner events and individual donations. Learn more about the Vera Bradley Foundation for Breast Cancer at www.verabradley.org.

Three Rivers Running Company has teamed up with the Vera Bradley Foundation for Breast Cancer research to help raise funds for life-saving research at the Vera Bradley Foundation Center for Breast Cancer Research at the Indiana University School of Medicine in Indianapolis, Indiana.

Vera Bradley Co-founders Barbara Bradley Baekgaard and Patricia R. Miller began raising funds for breast cancer research in 1993 after the loss of their dear friend, Mary Sloan. Since then, their genuine commitment to this cause has evolved into the Vera Bradley Foundation for Breast Cancer. The Vera Bradley Foundation for Breast Cancer is focused solely on investing in breast cancer research. Currently, the Foundation funds research at the Vera Bradley Foundation Center for Breast Cancer Research at the Indiana University School of Medicine in Indianapolis.

Only in the Vera Bradley Foundation Center for Breast Cancer Research are researchers able to pinpoint the perfect drug or drugs to fight breast tumors and sync this knowledge with each woman’s genetic and personal profile. It’s exciting for us to know that this work—that will impact care everywhere—is only possible because of funding from the Vera Bradley Foundation.

Monogrammed Medicine is unique because researchers at the Indiana University School of Medicine are designing therapies that consider both the genetics of the tumor and the woman it has invaded. Researchers are learning how to predict and adjust if a patient lacks a critical enzyme to metabolize a drug, or if the antacid she takes interferes with treatment effectiveness, or if the treatment will be too toxic for her to withstand. Threading these intricate strands of information means that the breast cancer therapy prescribed is hers and hers alone. It’s Monogrammed Medicine. Together with donors, event participants, and volunteers, we hope for a future free from breast cancer.

Let’s work together to end breast cancer, one stride at a time.